Peptide YY Physiology and Related Medicines Peptide YY (PYY) is co-secreted with GLP-1 by endocrine cells in the intestine and converted to its active form PYY 3-36, which acts via Y2 receptors to inhibit neuropeptide Y (NPY) neurons and promote satiety 1,22
While genetic factors do not predict exact medication response, they can support a conversation with your provider about personalizationand proper medication storage ensures that genetic potential translates into clinical effectiveness
However, both Novo Nordisk and Eli Lilly have downplayed the severity of the gastrointestinal events caused by Ozempic and Mounjaro, never, for example, warning of the risk of gastroparesis or gastroenteritis, the lawsuit states
However, guidelines may vary based on individual health conditions, so its best to consult with your doctor for a personalized plan.
Why the IV-to-subcutaneous gap is not a technicality For many peptides, moving from IV to subcutaneous changes the pharmacokinetics modestly a slower rise, a lower peak, decent bioavailability
